RESEARCH LETTER
 
TOPICS
 
REFERENCES (18)
1.
Munoz M, Robinson K, Shibli-Rahhal A. Bone health and osteoporosis prevention and treatment. Clin Obstet Gynecol 2020; 63: 770-87.
 
2.
Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006; 194 (2 Suppl): S3-11.
 
3.
Force USPST, Curry SJ, Krist AH, et al. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. JAMA 2018; 319: 2521-31.
 
4.
Civitelli R, Armamento-Villareal R, Napoli N. Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int 2009; 20: 843-51.
 
5.
Krege JH, Lane NE, Harris JM, et al. PINP as a biological response marker during teriparatide treatment for osteoporosis. Osteoporos Int 2014; 25: 2159-71.
 
6.
Shi H, Jiang X, Xu C, et al. MicroRNAs in serum exosomes as circulating biomarkers for postmenopausal osteoporosis. Front Endocrinol (Lausanne) 2022; 13: 819056.
 
7.
Senel K, Baykal T, Seferoglu B, et al. Circulating vascular endothelial growth factor concentrations in patients with postmenopausal osteoporosis. Arch Med Sci 2013; 9: 709-12.
 
8.
Drake MT, Clarke BL, Oursler MJ, et al. Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned. Endocr Rev 2017; 38: 325-50.
 
9.
Rochette L, Meloux A, Rigal E, et al. The role of osteoprotegerin and its ligands in vascular function. Int J Mol Sci 2019; 20: 705.
 
10.
Udagawa N, Koide M, Nakamura M, et al. Osteoclast differentiation by RANKL and OPG signaling pathways J Bone Miner Metab 2021; 39: 19-26.
 
11.
Xiao PL, Cui AY, Hsu CJ, et al. Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis. Osteoporos Int 2022; 33: 2137-53.
 
12.
Madsen JOB, Jorgensen NR, Pociot F, et al. Bone turnover markers in children and adolescents with type 1 diabetes-a systematic review. Pediatr Diabetes 2019; 20: 510-22.
 
13.
Su C, Wang H, Xu L, et al. MALAT1/miR-320a in bone marrow mesenchymal stem cells function may shed light on mechanisms underlying osteoporosis. Arch Med Sci 2021; 18: 1638-49.
 
14.
Chai J, Xu L, Liu N. miR-23b-3p regulates differentiation of osteoclasts by targeting PTEN via the PI3k/AKT pathway. Arch Med Sci 2019; 18: 1542-57.
 
15.
Barry ZT, Platt MO. Cathepsin S cannibalism of cathepsin K as a mechanism to reduce type I collagen degradation. J Biol Chem 2012; 287: 27723-30.
 
16.
Song QL, Y. Research progress on cathepsin K and treatment of osteoporosis. Chin J Prev Contr Chron Dis 2014; 22: 498-51.
 
17.
Suarjana IN, Isbagio H, Soewondo P, et al. The role of serum expression levels of microrna-21 on bone mineral density in hypostrogenic postmenopausal women with osteoporosis: study on level of RANKL, OPG, TGFbeta-1, sclerostin, RANKL/OPG ratio, and physical activity. Acta Med Indones 2019; 51: 245-52.
 
18.
Šimundić A. Measures of diagnostic accuracy: basic definitions. EJIFCC 2009; 19: 203-11.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top